Platform

GTCR Purchases Zentiva from Advent

Zentiva

Announced Thursday, April 9, 2026

GTCR

Deal Summary

Zentiva is a pharmaceutical company specializing in the development and manufacture of generic medicines.

Target	Zentiva
Buyer	GTCR

Source

“GTCR completes acquisition of Zentiva from Advent”

Related Deals